Vis enkel innførsel

dc.contributor.authorBraseth, Turid Aarhus
dc.contributor.authorHervig, Tor
dc.contributor.authorRøsvik, Anne Synnøve
dc.date.accessioned2018-04-19T07:25:03Z
dc.date.available2018-04-19T07:25:03Z
dc.date.created2017-06-15T14:02:32Z
dc.date.issued2017
dc.identifier.citationTransfusion and Apheresis Science. 2017, 56 (3), 485-489.nb_NO
dc.identifier.issn1473-0502
dc.identifier.urihttp://hdl.handle.net/11250/2494912
dc.description.abstractThe voluntary, unpaid, altruistic blood donor is a cornerstone of current transfusion medicine. The complexity of medical and ethical issues related to blood donation and hemochromatosis has led to a large number of studies related to the safety of the hemochromatosis donor and the quality of the blood components produced from these donations. The issue of accepting persons with HC as blood donors is diverting, both in Europe and worldwide and without joint guidelines. A questionnaire-based study was performed and mailed to all 25 blood bank leaders in Norway. Descriptive analysis was used to evaluate the data. Eight of 22 blood banks strictly followed national guidelines concerning persons with hemochromatosis. Other blood banks make local adjustments. 16 of 22 responding blood banks accept hemochromatosis donors and five do not, and one answered partly yes. The reasons the blood bank leaders supported the acceptance of hemochromatosis donors differ. Based on published papers and the present questionnaire, we believe that a clear definition of the “hemochromatosis donor” and guidelines with more detailed information on an acceptable donation regime would be important to overcome the weak points in blood donor eligibility criteria.nb_NO
dc.language.isoengnb_NO
dc.publisherElseviernb_NO
dc.titleHemochromatosis and blood donationnb_NO
dc.typeJournal articlenb_NO
dc.description.versionsubmittedVersionnb_NO
dc.source.pagenumber485-489nb_NO
dc.source.volume56nb_NO
dc.source.journalTransfusion and Apheresis Sciencenb_NO
dc.source.issue3nb_NO
dc.identifier.doi10.1016/j.transci.2017.05.012
dc.identifier.cristin1476416
dc.description.localcodeThis is a submitted manuscript of an article published by Elsevier Ltd in Transfusion and Apheresis Science, 18 May 2017.nb_NO
cristin.unitcode194,66,45,0
cristin.unitnameInstitutt for biologiske fag Ålesund
cristin.ispublishedtrue
cristin.fulltextpreprint
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel